Методы оценки коморбидности и ее роль у пациентов с кардиологической патологией

Коморбидность как важная компонента патофизиологических процессов, что существенно влияет на течение и исход кардиологических заболеваний у пациентов. Оценка степени вклада коморбидности в общее состояние организма. Шкалы и индексы коморбидности.

Рубрика Медицина
Вид статья
Язык русский
Дата добавления 28.02.2024
Размер файла 293,1 K

Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже

Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.

28. Groll D. L., To T., Bombardier C., Wright J. G. The development of a comorbidity index with physical function as the outcome. J. Clin. Epidemiol., 2005, vol. 58, no. 6, рр. 595-602.

29. Preedy V. R., Watson R. R. Handbook of Disease Burdens and Quality of Life Measures. New York, Springer, 2010.

30. Litwin M. S., Greenfield S., Elkin E. P. Assessment of Prognosis with the Total Illness Burden Index for Prostate Cancer. Cancer, 2007, vol. 109, no. 9, pp. 83-177.

31. Hall S. F. What is best comorbidity index for retrospective survival studies in head and neck oncology.Toronto, [s. n.], 2001, 135 p.

32. Komissarova S. M., Zakharova E. Yu., Sevruk Т. V., Ustinova I. B., Krasko O. V. Predictive value of the global longitudinal strain in hypertrophic cardiomyopathy patients. Russian Journal of Cardiology, 2018, no. 2, pp. 7-12. (In Russian)

33. Komajda M., Cosentino F., Ferrari R., Kerneis M., Kosmachova E., Laroche C., Maggioni A. P., Rittger H., Steg P. G., Szwed H., Tavazzi L., Valgimigli M., Gale C. P. Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry. Eur. J. Cardiol., 2021, vol. 28, no. 4, pp. 432-445.

34. Van Manen J. G., Korevaar J. C., Dekker F. W., Boeschoten E. W., Bossuyt P. M., Krediet R. T. How to adjust for comorbidity in survival studies in ESRD patients: A comparison of different indices. American Journal of Kidney Diseases, 2002, vol. 40, no. 1, pp. 82-89.

35. Hemmelgarn B. R., Manns B. J., Quan H., Ghali W. A. Adapting the Charlson comorbidity index for use in patients with ESRD. American Journal of Kidney Diseases, 2003, vol. 42, no. 1, Suppl. 2, pp. 125-132.

36. Daly C. A., De Stavola B., Fox K. M. Predicting prognosis in stable angina-results from the Euro heart survey of stable angina: Prospective observational study. British Medical Journal, 2006, vol. 332, no. 7536, pp. 262-267.

37. Bhatt D. L., Steg P. G., Ohman E. M., Hirsch A. T., Ikeda Y., Mas J. L., Goto S., Liau C. S., Richard A. J., Rцther J., Wilson P. W. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. J. Am. Med. Assoc., 2006, vol. 295, no. 2, pp. 180-189.

38. Sorbets E., Fox K. M., Elbez Y., Danchin N., Dorian P., Ferrari R., Ford I., Greenlaw N., Kalra P. R., Parma Z., Shalnova S., Tardif J. C., Tendera M., Zamorano J. L., Vidal-Petiot E., Steg P. G. Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry. Eur. Heart J., 2020, vol. 41, no. 3, pp. 347-356.

39. Barbarash O. L., Kashtalap V. V., Shibanova I. A. Cardiovascular comorbidity: Patient with coronary artery disease and peripheral artery atherosclerosis. How to identify and manage the risks of ischemic events? Rational Pharmacotherapy in Cardiology, 2020, vol. 16, no. 4, pp. 607-613.

40. Zykov M. V., D'yachenko N. V., Trubnikova O. A., Erlih A. D., Kashtalap V. V., Barbarash O. L. Comorbidity and gender of patients at risk of hospital mortality after emergency percutaneous coronary intervention. Kardiologiya, 2020, vol. 60, no. 9, pp. 38-45. (In Russian)

41. Frolova Y. V., Sysoev S. Y., Tyurina E. A., Nikoda V. V., Zaytsev A. Y., Dymova O. V., Bedzhanyan A. L. Impact of comorbid chronic heart failure with preserved left ventricular ejection fraction on the management of elderly cancer patients before and after total resections. Khirurgiya. Zhurnal im.

N. I. Pirogova, 2021, vol. 6, no. 2, pp. 45-51. (In Russian)

42. Yeh E. T. H., Bickford C. L. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. Journal of the American College of Cardiology, 2009, vol. 53, no. 24, pp. 2231-2247.

43. Palumbo A., Rajkumar S. V., Dimopoulos M. A., Richardson P. G., San Miguel J., Barlogie B., Harousseau J., Zonder J. A., Cavo M., Zangari M., Attal M., Belch A., Knop S., Joshua D., Sezer O., Ludwig H., Vesole D., Bladй J., Kyle R., Westin J., Weber D., Bringhen S., Niesvizky R., Waage A., von Lilienfeld-Toal M., Lonial S., Morgan G. J., Orlowski R. Z., Shimizu K., Anderson K. C., Boccadoro M., Durie B. G., Sonneveld P., Hussein M. A. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia, 2008, vol. 22, no. 2, pp. 414-423.

44. Korzh A. Cardiorenal syndrome: clinical significance, diagnostic criteria, and principles of treatment.

Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicine, 2016, vol. 2, pp. 37-42.

45. Rodrigo E., Pich S., Subirana I., Fernandez-Fresnedo G., Barreda P., Ferrer-Costa C., M. de Fran- cisco Б. L., Salas E., Elosua R., Arias M. A clinical-genetic approach to assessing cardiovascular risk in patients with CKD. Clin. Kidney J., 2017, vol. 10, no. 5, pp. 672-678.

46. Easyan A. M. Chronic renal disease: risk factors, early detection, principles of antihypertensive thera- py. Medical Council, 2017, no. 12, pp. 18-25.

47. Zueva T., Zhdanov T., Urazlina S. Comorbidity of renal and cardiac pathology. Medical news of the North Caucasus, 2019, vol. 14, no. 4, pp. 711-717.

48. United States Renal Data System. USRDS Annual Data Report. ESRD in the United States. 2018, vol. 2, pp. 183-598.

49. Collins A. J., Vassalotti J. A., Wang C., Li S., Gilbertson D. T., Liu J., Foley R. N., Chen S. C., Arneson T. J. Who Should Be Targeted for CKD Screening? Impact of Diabetes, Hypertension, and Cardiovascular Disease. American Journal of Kidney Diseases, 2009, vol. 53, no. 3, pp. S71-S77.

50. Morozova T. E., Popova T. S., Barabanova E. A., Samokhina E. O. The “Comorbid Patient” Scale as a General practitioner's tool to increase treatment adherence in patients living in rural areas. Sechenov Medical Journal, 2021, vol. 11, no. 4, pp. 50-59. (In Russian)

Размещено на Allbest.ru

...

Подобные документы

Работы в архивах красиво оформлены согласно требованиям ВУЗов и содержат рисунки, диаграммы, формулы и т.д.
PPT, PPTX и PDF-файлы представлены только в архивах.
Рекомендуем скачать работу.